Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianluca Pirozzi

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
American Journal of Hematology|December 9, 2024
The Importance of Controlling Terminal Complement Activity and Intravascular Hemolysis in Paroxysmal Nocturnal Hemoglobinuria (PNH)Anita Hill, Christophe Hotermans, Gianluca Pirozzi
The New England Journal of Medicine|September 27, 2013
Dupilumab in persistent asthmaSally E Wenzel, Lin Wang, Gianluca Pirozzi
Expert Review of Clinical Immunology|March 10, 2017
Commonality of the IL-4/IL-13 pathway in atopic diseasesNamita A Gandhi, Gianluca Pirozzi, Neil M H Graham
Blood|August 19, 2004
p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cellsSimona Pisegna, Gianluca Pirozzi, Mario Piccoli, et al.
Lancet (London, England)|December 8, 2016
Severe asthma and asthma-chronic obstructive pulmonary disease syndrome - Authors' replySally E Wenzel, Shyamalie Jayawardena, Neil M H Graham, et al.
Plos One|April 10, 2008
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cellsDaniel Scott-Algara, Vincent Arnold, Céline Didier, et al.
Nature Reviews. Drug Discovery|October 17, 2015
Targeting key proximal drivers of type 2 inflammation in diseaseNamita A Gandhi, Brandy L Bennett, Neil M H Graham, et al.
Journal of the American Academy of Dermatology|January 19, 2016
Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adultsEric L Simpson, Thomas Bieber, Laurent Eckert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cellsSimona Pisegna, Alessandra Zingoni, Gianluca Pirozzi, et al.
Clinical Pharmacology in Drug Development|February 26, 2020
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 DataPavel Kovalenko, John D Davis, Meng Li, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|December 9, 2024
The Importance of Controlling Terminal Complement Activity and Intravascular Hemolysis in Paroxysmal Nocturnal Hemoglobinuria (PNH)Anita Hill, Christophe Hotermans, Gianluca Pirozzi
The New England Journal of Medicine|September 27, 2013
Dupilumab in persistent asthmaSally E Wenzel, Lin Wang, Gianluca Pirozzi
Expert Review of Clinical Immunology|March 10, 2017
Commonality of the IL-4/IL-13 pathway in atopic diseasesNamita A Gandhi, Gianluca Pirozzi, Neil M H Graham
Blood|August 19, 2004
p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cellsSimona Pisegna, Gianluca Pirozzi, Mario Piccoli, et al.
Lancet (London, England)|December 8, 2016
Severe asthma and asthma-chronic obstructive pulmonary disease syndrome - Authors' replySally E Wenzel, Shyamalie Jayawardena, Neil M H Graham, et al.
Plos One|April 10, 2008
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cellsDaniel Scott-Algara, Vincent Arnold, Céline Didier, et al.
Nature Reviews. Drug Discovery|October 17, 2015
Targeting key proximal drivers of type 2 inflammation in diseaseNamita A Gandhi, Brandy L Bennett, Neil M H Graham, et al.
Journal of the American Academy of Dermatology|January 19, 2016
Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adultsEric L Simpson, Thomas Bieber, Laurent Eckert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cellsSimona Pisegna, Alessandra Zingoni, Gianluca Pirozzi, et al.
Clinical Pharmacology in Drug Development|February 26, 2020
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 DataPavel Kovalenko, John D Davis, Meng Li, et al.
Pageof 5